Botox: Current and Emerging Trends for Dental Practitioners in Esthetic Dentistry

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Aug 8

PMID 39114247

Authors

Ojasvi Rambole

Amit Reche

Priyanka Paul

Affiliations

Soon will be listed here.

Abstract

There are numerous medical and dental disorders for which there are no effective traditional therapy options. For various medical and dental disorders, botulinum toxin (BT) can be employed as an alternate therapeutic option that uses the chemodenervation approach. The range of dentistry treatment choices is expanding quickly. Applications of non-traditional therapy alternatives, such as the use of BT, are becoming more and more common in this situation. Although BT has been shown to be effective in a number of circumstances, its application in esthetic operations, such as the treatment of facial wrinkles, has gained widespread acceptance. This research is especially interested in applications of BT related to dentistry in the craniofacial region. For many diseases that a dentist would be interested in treating, BT provides a temporary, reversible, and generally safe therapy option. Due to their extensive knowledge of the anatomy of the faciomaxillary region, dental surgeons are a potential pool of operators who, with a small amount of skill enhancement, can use BT in their toolkit. This broadens the scope of minimally invasive alternatives to invasive protocols or refractory conditions. An online search was conducted for the use of BT in dentistry; all studies and articles pertaining to the subject were chosen, and dental-related content was removed and summarized. The fundamentals of BT and some of its applications in dentistry are covered in this article. The comprehensive details of its application in dentistry will be covered in the upcoming sections.

References

On A, Kirazli Y, Kismali B, Aksit R . Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil. 1999; 78(4):344-9. DOI: 10.1097/00002060-199907000-00010. View

Freund B, Schwartz M, Symington J . The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg. 1999; 57(8):916-20; discussion 920-1. DOI: 10.1016/s0278-2391(99)90007-1. View

Fu J, Ngo A, Shin K, Bruera E . Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. J Palliat Med. 2013; 16(12):1637-40. PMC: 3868262. DOI: 10.1089/jpm.2013.0182. View

. Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B). Plast Surg Nurs. 2008; 28(3):150-1. DOI: 10.1097/01.PSN.0000335818.00036.c5. View

Aoki K . Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003; 43 Suppl 1:S9-15. DOI: 10.1046/j.1526-4610.43.7s.3.x. View

Capaccio P, Torretta S, Osio M, Minorati D, Ottaviani F, Sambataro G . Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders. Am J Otolaryngol. 2008; 29(5):333-8. DOI: 10.1016/j.amjoto.2007.10.003. View

Bohluli B, Motamedi M, Bagheri S, Bayat M, Lassemi E, Navi F . Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 111(1):47-50. DOI: 10.1016/j.tripleo.2010.04.043. View

Parkash S, Ramakrishnan K . Gustatory syndrome following radical neck dissection. Aust N Z J Surg. 1983; 53(5):491-2. DOI: 10.1111/j.1445-2197.1983.tb02492.x. View

Hockstein N, Samadi D, Gendron K, Handler S . Sialorrhea: a management challenge. Am Fam Physician. 2004; 69(11):2628-34. View

10.

Olivo S, Bravo J, Magee D, Thie N, Major P, Flores-Mir C . The association between head and cervical posture and temporomandibular disorders: a systematic review. J Orofac Pain. 2006; 20(1):9-23. View

11.

Laskawi R, Ellies M . The role of botulinum toxin in the management of head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2007; 15(2):112-6. DOI: 10.1097/MOO.0b013e328014731c. View

12.

Tan E, Jankovic J . Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000; 131(2):211-6. DOI: 10.14219/jada.archive.2000.0149. View

13.

Long H, Liao Z, Wang Y, Liao L, Lai W . Efficacy of botulinum toxins on bruxism: an evidence-based review. Int Dent J. 2012; 62(1):1-5. PMC: 9374973. DOI: 10.1111/j.1875-595X.2011.00085.x. View

14.

Singh S, Davis H, Wilson P . Axillary hyperhidrosis: A review of the extent of the problem and treatment modalities. Surgeon. 2015; 13(5):279-85. DOI: 10.1016/j.surge.2015.03.003. View

15.

Al-Qattan M, Al-Shanawani B, Alshomer F . Botulinum toxin type A: implications in wound healing, facial cutaneous scarring, and cleft lip repair. Ann Saudi Med. 2013; 33(5):482-8. PMC: 6074896. DOI: 10.5144/0256-4947.2013.482. View

16.

Simpson L . Botulinum toxin: potent poison, potent medicine. Hosp Pract (1995). 1999; 34(4):87-91; quiz 163. DOI: 10.3810/hp.1999.04.136. View

17.

Polo M . Botulinum toxin type A in the treatment of excessive gingival display. Am J Orthod Dentofacial Orthop. 2005; 127(2):214-8. DOI: 10.1016/j.ajodo.2004.09.013. View

18.

Dalla Toffola E, Furini F, Redaelli C, Prestifilippo E, Bejor M . Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010; 32(17):1414-8. DOI: 10.3109/09638280903514697. View

19.

Philouze P, Vertu D, Ceruse P . Bilateral gustatory sweating in the submandibular region after bilateral neck dissection successfully treated with botulinum toxin. Br J Oral Maxillofac Surg. 2014; 52(8):761-3. DOI: 10.1016/j.bjoms.2014.06.008. View

20.

Meunier F, Schiavo G, Molgo J . Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris. 2002; 96(1-2):105-13. DOI: 10.1016/s0928-4257(01)00086-9. View